Misdiagnosis Between Interstitial Lung Disease and Cardiac Patients
NCT ID: NCT06198608
Last Updated: 2024-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
80 participants
OBSERVATIONAL
2024-01-01
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To identify specific HRCT findings that are more commonly associated with misdiagnosis versus correct diagnosis of the underlying condition.
To establish diagnostic criteria or HRCT patterns that distinguish cardiac congestion from interstitial lung disease
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic Criteria in Cardiac Sarcoidosis
NCT04737317
Coronary CT Angiography Using 320-Row Volume CT in Patients With Atrial Fibrillation
NCT00968279
Outpatient Evaluation of Patients With Known or Suspected Heart Disease
NCT00001400
Dyspnea in Stable Patients With Coronary Artery Disease.
NCT04408612
Evaluation of the CardioSond Electronic Stethoscope in the Detection of Coronary Artery Disease
NCT01374555
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Misdiagnosis can lead to inappropriate treatment with immunosuppressive drugs which could exacerbate right heart failure in patients who actually have cardiac congestion. Correct diagnosis is important for prognosis and management.
Subtle findings like upper lobe predominance of opacities, septal lines and a mosaic attenuation pattern on HRCT favor interstitial lung disease, while diffuse ground glass with central and perihilar distribution favors cardiac congestion .
Associated findings on HRCT like enlarged cardiac silhouette, pleural and pericardial effusions help suggest the diagnosis of cardiac congestion over idiopathic interstitial pneumonia .
Integrating clinical data on risk factors for heart failure, echocardiography findings and follow-up imaging response to diuretic therapy can help differentiate the two conditions when HRCT is non-specific
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Initial radiology report included a definitive diagnosis of interstitial lung disease patterns
* Age 18+ years
* No prior history of pulmonary or cardiac
Exclusion Criteria
* Underlying diagnosis other than interstitial lung disease or cardiac congestion
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hend Mohamed Sayed Mohamed
doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
marwan sayed, MD
Role: STUDY_CHAIR
lecture in cardiac diseases
samaa elkossi, MD
Role: STUDY_CHAIR
Lecture inradiology departement
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Nathan SD, Pastre J, Ksovreli I, Barnett S, King C, Aryal S, Ahmad K, Fukuda C, Ramalingam V, Chung JH. HRCT evaluation of patients with interstitial lung disease: comparison of the 2018 and 2011 diagnostic guidelines. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620968496. doi: 10.1177/1753466620968496.
Case AH, Beegle S, Hotchkin DL, Kaelin T, Kim HJ, Podolanczuk AJ, Ramaswamy M, Remolina C, Salvatore MM, Tu C, de Andrade JA. Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey. BMJ Open Respir Res. 2023 Nov 24;10(1):e001594. doi: 10.1136/bmjresp-2022-001594.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ILD&Cardiac patient
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.